Christopher Gamper

Medicine & Life Sciences

1. Haploidentical Transplantation 100%
2. Cyclophosphamide 95%
3. Bone Marrow Transplantation 68%
4. DNA methyltransferase 3A 61%
5. TNF Receptor-Associated Factor 3 60%
6. T-Lymphocytes 57%
7. Transplantation 57%
8. Pediatrics 53%
9. Graft vs Host Disease 53%
10. Hematologic Neoplasms 45%
11. Hematopoietic Stem Cell Transplantation 44%
12. Sickle Cell Anemia 42%
13. Tissue Donors 35%
14. Sirolimus 34%
15. Young Adult 30%
16. Aplastic Anaemia 29%
17. Transplants 27%
18. Residual Neoplasm 27%
19. Whole-Body Irradiation 27%
20. DNA Methylation 26%
21. nuclear pore protein p62 24%
22. Hoyeraal Hreidarsson syndrome 24%
23. Leukemia 23%
24. Recurrence 23%
25. Clonal Anergy 20%
26. Hemoglobinopathies 20%
27. Child 20%
28. Neutropenia, Severe Congenital, Autosomal Recessive 3 19%
29. Sinus Histiocytosis 18%
30. Nuclear Pore 16%
31. Peripheral Blood Stem Cell Transplantation 16%
32. HLA Antigens 15%
33. Antilymphocyte Serum 15%
34. Mutation 15%
35. Acute Myeloid Leukemia 15%
36. Mechanistic Target of Rapamycin Complex 1 15%
37. Cell Differentiation 15%
38. Cell Transplantation 15%
39. T-Cell Antigen Receptor 14%
40. Allogeneic Cells 13%
41. Methyltransferases 13%
42. Lymphadenopathy 12%
43. Blood Culture 12%
44. Incidence 12%
45. Mortality 12%
46. Progression-Free Survival 12%
47. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12%
48. Quality Improvement 12%
49. Bone Marrow 12%